Nitric Oxide Induces Apoptosis in Spleen Lymphocytes from MRL/lpr Mice

Journal of Investigative Medicine

Volumn 52, Issue 1, 2004, Pages 62-71

  Oates, Jim C ^a   Gilkeson, Gary S ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Lupus; Nitric oxide

Indexed keywords

ENZYME INHIBITOR; FAS ANTIGEN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ADOLESCENT; ANIMAL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; AUTOIMMUNE DISEASE; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; EX VIVO STUDY; FEMALE; LEUKOCYTE; LYMPHOCYTE; METABOLISM; MOUSE; MOUSE STRAIN; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NONHUMAN; PATHOLOGY; PHYSIOLOGY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SPLEEN; SPLEEN LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALIA; MURINAE;

EID: 1342346535     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.1136/jim-52-01-29     Document Type: Conference Paper

References (65)

1. Mariani SM, Matiba B, Armandola EA, Krammer PH. The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur J Immunol 1994;24:3119-23.
2. Singh AK. Lupus in the Fas lane? J R Coll Phys Lond 1995;29:475-8.
3. + T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J Immunol 1993;151:7233-9.
4. Van Houten N, Budd RC. Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes. J Immunol 1992;149:2513-7.
5. Weinberg JB, Granger DL, Pisetsky DS, et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 1994;179:651-60.
6. Oates JC, Ruiz P, Alexander A, et al. Effect of late modulation of nitric oxide production on murine lupus. Clin Immunol Immunopathol 1997;83:86-92.
7. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994;120:227-37.
8. Mills CD, Stevens RB, Sutherland DE. Nitric oxide in autoimmunity and cell transplantation. Transplant Proc 1994;26:3348.
9. Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
10. McInnes IB, Leung BP, Field M, et al. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996;184:1519-24.
11. St Clair EW, Wilkinson WE, Lang T, et al. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med 1996;184:1173-8.
12. Shimaoka M, Iida T, Ohara A, et al. NOC, a nitric-oxide-releasing compound, induces dose dependent apoptosis in macrophages. Biochem Biophys Res Commun 1995;209:519-26.
13. Kitajima I, Kawahara K, Nakajima T, et al. Nitric oxide-mediated apoptosis in murine mastocytoma. Biochem Biophys Res Commun 1994;204:244-51.
14. Cui S, Reichner JS, Mateo RB, Albina JE. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res 1994;54:2462-7.
15. Ankarcrona M, Dypbukt JM, Brune B, Nicotera P. Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 1994;213:172-7.
16. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993;150:5080-5.
17. Fehsel K, Kroncke KD, Meyer KL, et al. Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 1995;155:2858-65.
18. Genaro AM, Hortelano S, Alvarez A, et al. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 1995;95:1884-90.
19. Lin KT, Xue JY, Nomen M, et al. Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem 1995;270:16487-90.
20. Beauvais F, Michel L, Dubertret L. The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils. FEBS Lett 1995;361:229-32.
21. Mannick JB, Asano K, Izumi K, et al. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994;79:1137-46.
22. Reilly CM, Farrelly LW, Viti D, et al. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase. Kidney Int 2002;61:839-46.
23. Keefer LK, Nims RW, Davies KM, Wink DA. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol 1996;268:281-93.
24. Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol 1996;268:142-51.
25. Koopman G, Reutelingsperger CP, Kuijten GA, et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-20.
26. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J Immunol Methods 1995;184:39-51.
27. Darzynkiewicz Z, Bruno S, Del Bino G, et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808.
28. Watson ML, Rao JK, Gilkeson GS, et al. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med 1992;176:1645-56.
29. Musette P, Pannetier C, Gachelin G, Kourilsky P. The expansion of a CD4+ T cell population bearing a distinctive beta chain in MRL lpr/lpr mice suggests a role for the fas protein in peripheral T cell selection. Eur J Immunol 1994;24:2761-6.
30. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
31. Richardson BC, Yung RL, Johnson KJ, et al. Monocyte apoptosis in patients with active lupus. Arthritis Rheum 1996;39:1432-4.
32. Courtney PA, Crockard AD, Williamson K, et al. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999;58:309-14.
33. Perniok A, Wedekind F, Herrmann M, et al. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 1998;7:113-8.
34. Chan EY, Ko SC, Lau CS. Increased rate of apoptosis and decreased expression of bcl-2 protein in peripheral blood lymphocytes from patients with active systemic lupus erythematosus. Asian Pac J Allergy Immunol 1997;15:3-7.
35. Lorenz HM, Grunke M, Hieronymus T, et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1997;40:306-17.
36. Kanai Y, Kyuwa S, Miura K, Kurosawa Y. Induction and natural occurrence of serum nucleosomal DNA in autoimmune MRL/lpr/lpr mice: its relation to apoptosis in the thymus. Immunol Lett 1995;46:207-14.
37. Giudice ED, Ciaramella A, Balestro N, et al. Neutrophil apoptosis in autoimmune Fas-defective MRL lpr/lpr mice. Eur Cytokine Netw 2001;12:510-7.
38. Licht R, van Bruggen MC, Oppers-Walgreen B, et al. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolysaccharide administration. Arthritis Rheum 2001;44:1320-30.
39. Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998;188:387-92.
40. Wang B, Dong X, Yuan Z, et al. SSA/Ro antigen expressed on membrane of UVB-induced apoptotic keratinocytes is pathogenic but not detectable in supernatant of cell culture. Chin Med J (Engl) 1999;112:512-5.
41. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-30.
42. Rosen A, Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999;6:6-12.
43. Takeoka Y, Taguchi N, Shultz L, et al. Apoptosis and the thymic microenvironment in murine lupus. J Autoimmun 1999;13:325-34.
44. Ravirajan CT, Sarraf CE, Anilkumar TV, et al. An analysis of apoptosis in lymphoid organs and lupus disease in murine systemic lupus erythematosus (SLE). Clin Exp Immunol 1996;105:306-12.
45. Noel PJ, Boise LH, Thompson CB. Regulation of T cell activation by CD28 and CTLA4. Adv Exp Med Biol 1996;406:209-17.
46. Gribben JG, Freeman GJ, Boussiotis VA, et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci U S A 1995;92:811-5.
47. Lucas M, Sanchez-Margalet V. Protein kinase C involvement in apoptosis. Gen Pharmacol 1995;26:881-7.
48. Potter PK, Cortes-Hernandez J, Quartier P, et al. Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J Immunol 2003;170:3223-32.
49. Mitchell DA, Pickering MC, Warren J, et al. Clq deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol 2002;168:2538-43.
50. Laderach D, Bach JF, Koutouzov S. Nucleosomes inhibit phagocytosis of apoptotic thymocytes by peritoneal macrophages from MRL+/+ lupus-prone mice. J Leukoc Biol 1998;64:774-80.
51. Boyd CS, Cadenas E. Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol Chem 2002;383:411-23.
52. Moulian N, Truffault F, Gaudry-Talarmain YM, et al. In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation. Blood 2001;97:3521-30.
53. Bustamante J, Bersier G, Romero M, et al. Nitric oxide production and mitochondrial dysfunction during rat thymocyte apoptosis. Arch Biochem Biophys 2000;376:239-47.
54. Bustamante J, Bersier G, Badin RA, et al. Sequential NO production by mitochondria and endoplasmic reticulum during induced apoptosis. Nitric Oxide 2002;6:333-41.
55. Tai XG, Toyo-oka K, Yamamoto N, et al. Expression of an inducible type of nitric oxide (NO) synthase in the thymus and involvement of NO in deletion of TCR-stimulated double-positive thymocytes. J Immunol 1997;158:4696-703.
56. Lu L, Bonham CA, Chambers FG, et al. Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol 1996;157:3577-86.
57. Ramirez R, Carracedo J, Castedo M, et al. CD69-induced monocyte apoptosis involves multiple nonredundant signaling pathways. Cell Immunol 1996;172:192-9.
58. Aiello S, Noris M, Piccinini G, et al. Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigens. J Immunol 2000;164:4649-58.
59. Mannick JB, Miao XQ, Stamler JS. Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem 1997;272:24125-8.
60. Mannick JB, Hausladen A, Liu L, et al. Fas-induced caspase denitrosylation. Science 1999;284:651-4.
61. Mozart M, Scuderi R, Celsing F, Aguilar-Santelises M. Nitric oxide induces apoptosis in NALM-6, a leukaemia cell line with low cyclin E protein levels. Cell Prolif 2001;34:369-78.
62. Messmer UK, Lapetina EG, Brune B. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol Pharmacol 1995;47:757-65.
63. Jun CD, Oh CD, Kwak HJ, et al. Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways. J Immunol 1999;162:3395-401.
64. Rifkin IR, Channavajhala PL, Kiefer HL, et al. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha. J Immunol 1998;161:5164-70.
65. Ohkusu K, Isobe K, Hidaka H, Nakashima I. Elucidation of the protein kinase C-dependent apoptosis pathway in distinct subsets of T lymphocytes in MRL-lpr/lpr mice. Eur J Immunol 1995;25:3180-6.